Commentary: Global Alzheimer's disease and Alzheimer's disease related dementia research funding organizations support and engage the research community throughout the COVID-19 pandemic.

Alzheimer's disease COVID-19 dementia nonprofit public health research funding

Journal

Alzheimer's & dementia : the journal of the Alzheimer's Association
ISSN: 1552-5279
Titre abrégé: Alzheimers Dement
Pays: United States
ID NLM: 101231978

Informations de publication

Date de publication:
05 2022
Historique:
received: 21 04 2021
accepted: 25 07 2021
pubmed: 2 10 2021
medline: 11 5 2022
entrez: 1 10 2021
Statut: ppublish

Résumé

The COVID-19 pandemic has disproportionately affected more vulnerable populations, including those living with dementia. Over 50 million individuals worldwide are living with Alzheimer's disease (AD) or other dementia, and it is crucial to continue the fight against the condition during the global pandemic. Since the start of mandated lockdowns in March 2020, charity and non-profit organizations that fund AD and related dementia research continue to respond to the needs of the AD research community, ensuring the momentum continues and accelerates. Members of the International Alzheimer's and Related Dementia Research Funder Consortium, a group of nearly 40 funding organizations that informally convene throughout the year to share updates and information, have taken a number of steps to ensure the continued support of the research community. Even during times of uncertainty, it is essential that the field moves forward to uncover preventions, diagnoses, and treatments for these diseases that affect many millions globally.

Identifiants

pubmed: 34596318
doi: 10.1002/alz.12472
pmc: PMC8646302
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1067-1070

Informations de copyright

© 2021 The Authors. Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.

Références

Nat Rev Nephrol. 2020 Oct;16(10):562-564
pubmed: 32760016
Alzheimers Dement. 2022 May;18(5):1067-1070
pubmed: 34596318
Nat Rev Neurosci. 2021 Jan;22(1):1-2
pubmed: 33173190
Elife. 2020 Nov 04;9:
pubmed: 33143847
Nat Med. 2020 Apr 16;:
pubmed: 32300212
Alzheimers Dement. 2021 Jun;17(6):1056-1065
pubmed: 33399270
J Pediatr Urol. 2020 Oct;16(5):715-716
pubmed: 32713792

Auteurs

Emily A Meyers (EA)

Medical & Scientific Relations, Alzheimer's Association, Chicago, Illinois, USA.

Philippe Amouyel (P)

Fondation Alzheimer, Paris, France.

Diane E Bovenkamp (DE)

BrightFocus Foundation, Clarksburg, Maryland, USA.

Maria C Carrillo (MC)

Medical & Scientific Relations, Alzheimer's Association, Chicago, Illinois, USA.

Geraldine Drexel De Buchy (GD)

Fondation Vaincre Alzheimer, Paris, France.

Magali Dumont (M)

Fondation Alzheimer, Paris, France.

Howard Fillit (H)

Alzheimer's Drug Discovery Foundation, New York, New York, USA.

Lauren Friedman (L)

Alzheimer's Drug Discovery Foundation, New York, New York, USA.

Gregor Henderson-Begg (G)

Alzheimer's Society UK, London, UK.

Jakub Hort (J)

Czech Alzheimer Foundation, Prague, Czech Republic.
Memory Clinic, Department of Neurology, Charles University, 2nd Faculty of Medicine and Motol University Hospital, Prague, Czech Republic.

Andrew Murtishaw (A)

Medical & Scientific Relations, Alzheimer's Association, Chicago, Illinois, USA.

Richard Oakley (R)

Alzheimer's Society UK, London, UK.

Maï Panchal (M)

Fondation Vaincre Alzheimer, Paris, France.

Sharyn L Rossi (SL)

BrightFocus Foundation, Clarksburg, Maryland, USA.

Rosa M Sancho (RM)

Alzheimer's Research UK, Cambridge, UK.

Linda Thienpont (L)

Alzheimer Forschung Initiative, Düsseldorf, Germany.

Wendy Weidner (W)

Alzheimer's Disease International, London, UK.

Heather M Snyder (HM)

Medical & Scientific Relations, Alzheimer's Association, Chicago, Illinois, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH